Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection in pre-filled syringe - 11.25 milligram(s) - leuprorelin

European Union - English - EMA (European Medicines Agency)

accord healthcare s.l.u. - leuprorelin mesilate - prostatic neoplasms - endocrine therapy - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

astellas pharma co. ltd - leuprorelin acetate - powder and solvent for solution for injection - 45 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin

Ireland - English - HPRA (Health Products Regulatory Authority)

astellas pharma co. ltd - leuprorelin acetate - powder and solvent for solution for injection - 22.5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin

Ireland - English - HPRA (Health Products Regulatory Authority)

astellas pharma co. ltd - leuprorelin acetate - powder and solvent for solution for injection - 7.5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin

Israel - English - Ministry of Health

kamada ltd, israel - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 22.5 mg - eligard is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

Israel - English - Ministry of Health

kamada ltd, israel - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 45 mg - eligard is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

Israel - English - Ministry of Health

kamada ltd, israel - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 7.5 mg - eligard is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

gp-pharm, s.a. - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - 22.5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin

New Zealand - English - Medsafe (Medicines Safety Authority)

abbvie limited - leuprorelin acetate 5 mg/ml - solution for injection - 5 mg/ml - active: leuprorelin acetate 5 mg/ml excipient: benzyl alcohol glacial acetic acid sodium chloride sodium hydroxide water for injection - lucrin (leuprorelin acetate) is indicated · in metastatic prostate cancer · in locally advanced prostate cancer, as an alternative to surgical castration · as an adjuvant treatment to radiotherapy in patients with high-risk localized or locally advanced prostate cancer · as an adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression